Insurance Companies Continue to Innovate

On October 1st, Cigna introduced a new policy that closely examines how doctors charge for services. It flags physicians who frequently bill for Level 4 or Level 5 visits. Those doctors might receive higher reimbursements compared to their counterparts. However, if claims appear unjustifiable, some of these higher-level visits could be downcoded, meaning they would only be recognized as one level lower. This affects certain codes, such as 99204–99205 for new patients, 99214–99215 for established patients, and 99244–99245 for consultations.

Cigna aims to combat overcoding and claims abuse, alleging that some doctors report more complex visits than what actually occurred. For instance, it’s possible to request a 40-minute encounter when the actual visit is just 10 minutes long. Practices like this, according to Cigna, lead to unnecessary costs for patients and employers.

However, coding isn’t solely about time; it’s also about the complexity of medical decisions. Current rules allow physicians to bill based on either the total time spent or the complexity involved. So, a doctor spending over 30 minutes managing multiple conditions, reviewing medications, or coordinating care could still get flagged, even if the documentation supports a higher code. This could prompt payment reductions and add more administrative hassle.

Many medical groups suggest that downcoding occurs automatically, but Cigna disputes that. They say this new policy is merely an additional review layer for a small subgroup of billing and providers. Yet, I’m concerned; even if it isn’t automatic right now, it seems like a step in that direction.

Medical complexity cannot really fit into a simple billing code. Take patients with conditions like hypertension or diabetes. They might look “normal” on paper, but visits often involve navigating medication adjustments, managing side effects, and getting insurance approvals. That’s definitely not a quick chat; it often takes 30 to 40 minutes.

Even routine tasks such as prescribing antibiotics can show cracks in this system. While it seems like a straightforward diagnosis to an insurance company, the reality is much more intricate. Confirming a diagnosis, offering substance use counseling, and preventing complications can take much longer than appears on paper, potentially fitting into a 99214 visit.

This new policy diminishes the time and judgment of physicians by tying reimbursements to diagnostic codes instead of actual clinical evaluations. It operates under the misguided belief that complexity is only found in “rare” or “serious” codes. In reality, outpatient care is filled with many subtleties that a single label simply can’t capture. This leads to a skewed perception of healthcare, punishing doctors for providing thorough care, which ultimately impacts patient quality.

With this policy, a well-documented, clinically valid high-level visit could be reimbursed as if it were a low-level visit, decreasing payment amounts. To recover these payments, doctors would have to appeal, resubmitting the entire medical record, an arduous process that doesn’t truly reflect a fair review. It appears to be downcoding based on Cigna’s own definition of what constitutes “complex,” which doesn’t truly align with real-world patient care.

This is more than just a minor change; it’s the beginning of a troubling trend. What’s to stop other companies from adopting similar practices? This starts with extra scrutiny on complex office visits but could eventually extend to procedures, imaging, or lab interpretations. Over time, insurance might dictate how medical practices are evaluated, not physicians.

At first glance, downcoding might seem like a technical adjustment, but it creates an overwhelming administrative burden. A downcoded visit triggers a complete appeal process. For larger health systems, this may be manageable, but smaller practices might struggle significantly. Appeals are already overwhelming the system, and implementing new risk-reduction methods could exacerbate this backlog.

When visits are fully documented but still downcoded, it sends a clear message—doctors’ judgments and time aren’t valued enough. I’ve noticed this pattern before. Prior approval was once a narrow mechanism for cost control, but now it eats up considerable doctor time and often delays essential care.

For example, I recently prescribed Xarelto for a patient diagnosed with deep venous thrombosis—a serious condition. The insurance denied coverage, and for several days, the patient was left scrambling for alternatives and going without necessary medication while waiting for authorization. This is just unacceptable. It highlights how layers of bureaucracy add not just paperwork but also risks to patient health.

Cigna’s downcoding policy poses similar risks. What starts with one insurer could soon become industry norms.

The healthcare system is already strained by bureaucracy. A 2016 survey showed that doctors spend nearly half of their working hours on administrative tasks. The Annals of Internal Medicine found burnout among physicians is at an all-time high, with over 60% reporting symptoms. Surprisingly, the main culprit isn’t patient care but the overwhelming paperwork that comes with it.

Moreover, the U.S. is on the brink of a doctor shortage. By 2036, we could face a deficit of up to 86,000 physicians. New requirements may drive doctors toward early retirement or non-clinical roles, all while reducing their time with patients. Just when we need more healthcare providers, policies like downcoding add further strain to an already burdened system.

Ultimately, patients will feel the brunt of these changes. As doctors become buried in paperwork, appointment wait times will increase, and essential communication and follow-up will suffer. Many small practices may face closure or be forced to merge with larger entities. In many cases, larger systems bill at higher rates, raising overall costs. Delays due to administrative hurdles can worsen a patient’s condition, resulting in more visits and potential hospitalizations.

While monitoring for fraud and overcoding is essential, this expanded downcoding approach lacks balance. It punishes the majority of doctors who code correctly alongside those who may not. The costs of policing shift to all practices, irrespective of their accuracy in billing. This approach doesn’t benefit patients—care won’t improve, access won’t expand, and safety won’t be enhanced. Instead, it leads to reduced reimbursements, delayed payments, and more paperwork.

There is a better way forward. Instead of penalizing all doctors, authorities should focus on true outliers. Transparency regarding the criteria for review and the outcomes of appeals is essential. We could streamline the process to allow for automatic revisions when proper documentation exists. Collaborating with physician groups, we can design monitoring systems that reduce abuses without infringing on clinical judgment. These solutions can conserve resources without imposing unwarranted barriers for both patients and physicians.

Doctors don’t seek a system without oversight; we want a balance—a policy that allows for necessary regulations without overwhelming burdens. Medicine is already complicated; we should aim to simplify, not complicate further.

As this policy takes effect, it’s worth pondering whether it genuinely improves care or merely makes it more difficult. If it’s the latter, we risk sliding down a path toward fewer doctors, longer waits, higher costs, and ultimately poorer patient outcomes.